26.11.2021 • NewsLinde

Linde and KazMunayGas in Clean Energy Pact

German industrial gases and technology company Linde has signed a Memorandum of Understanding with Kazakhstan’s state-owned oil and gas group KazMunayGas to jointly develop clean energy projects.

The first stage of cooperation will focus on exploring the opportunity to produce hydrogen and ammonia in Kazakhstan, using natural gas as feedstock and/or electrolysis (blue/green hydrogen and blue/green ammonia). Once the companies complete a feasibility study and successfully reach agreement, they will move forward with building a hydrogen/ammonia plant. They did not give a timescale for the project.

KazMunayGas has a consistent and balanced approach to decarbonization projects as part of its adopted Low-Carbon Development Program. Cooperation with the world’s leading companies is a priority in studying promising projects in this area,” said Alik Aidarbayev, chairman of the management board at KazMunayGas.

Linde formed a joint venture with ITM Power in January 2020 to provide industrial-scale green gas project services. ITM Linde Electrolysis combines ITM Power’s modular proton exchange membrane electrolyzer technology with Linde’s engineering, procurement and construction expertise.

Author: Elaine Burridge, Freelance Journalist

Linde has signed a Memorandum of Understanding with Kazakhstan’s state-owned...
Linde has signed a Memorandum of Understanding with Kazakhstan’s state-owned oil and gas group KazMunayGas to explore the feasibility of producing hydrogen and ammonia in Kazakhstan, using natural gas as feedstock and/or electrolysis (blue/green hydrogen and blue/green ammonia). (c) Linde

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read